DnB Asset Management AS increased its stake in shares of HCA Holdings, Inc. (NYSE:HCA) by 7.5% during the third quarter, Holdings Channel reports. The institutional investor owned 27,244 shares of the company’s stock after buying an additional 1,900 shares during the period. DnB Asset Management AS’s holdings in HCA Holdings were worth $2,060,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Lucus Advisors LLC increased its stake in shares of HCA Holdings by 46.2% in the second quarter. Lucus Advisors LLC now owns 4,450 shares of the company’s stock valued at $343,000 after buying an additional 1,407 shares in the last quarter. Conning Inc. increased its stake in shares of HCA Holdings by 0.4% in the second quarter. Conning Inc. now owns 7,100 shares of the company’s stock valued at $547,000 after buying an additional 30 shares in the last quarter. Deltec Asset Management LLC bought a new stake in shares of HCA Holdings during the second quarter valued at approximately $1,848,000. Investment House LLC increased its stake in shares of HCA Holdings by 0.7% in the second quarter. Investment House LLC now owns 43,605 shares of the company’s stock valued at $3,358,000 after buying an additional 295 shares in the last quarter. Finally, Pitcairn Co. increased its stake in shares of HCA Holdings by 0.3% in the second quarter. Pitcairn Co. now owns 10,972 shares of the company’s stock valued at $844,000 after buying an additional 31 shares in the last quarter. 71.15% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for HCA Holdings (NYSE:HCA)

Shares of HCA Holdings, Inc. (NYSE:HCA) traded up 0.35% on Friday, hitting $79.40. The stock had a trading volume of 1,207,538 shares. HCA Holdings, Inc. has a one year low of $60.07 and a one year high of $83.69. The stock has a market capitalization of $29.75 billion, a PE ratio of 12.57 and a beta of 0.74. The firm’s 50 day moving average is $73.94 and its 200-day moving average is $75.85.

HCA Holdings (NYSE:HCA) last announced its quarterly earnings results on Thursday, October 27th. The company reported $1.61 EPS for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.19. HCA Holdings had a negative return on equity of 43.65% and a net margin of 6.10%. The company earned $10.27 billion during the quarter, compared to analysts’ expectations of $10.41 billion. During the same period in the prior year, the company earned $1.17 EPS. HCA Holdings’s revenue was up 4.2% compared to the same quarter last year. Equities research analysts expect that HCA Holdings, Inc. will post $6.72 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was posted by Watch List News and is the propert of of Watch List News. If you are reading this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright legislation. The legal version of this article can be read at http://www.watchlistnews.com/dnb-asset-management-as-has-2060000-position-in-hca-holdings-inc-hca/1060515.html.

Several brokerages have recently commented on HCA. Zacks Investment Research raised HCA Holdings from a “hold” rating to a “buy” rating and set a $92.00 target price for the company in a report on Tuesday, October 18th. Wolfe Research began coverage on HCA Holdings in a report on Tuesday, October 25th. They set an “outperform” rating for the company. Avondale Partners downgraded HCA Holdings from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 9th. Mizuho downgraded HCA Holdings from a “buy” rating to a “neutral” rating in a report on Wednesday, November 9th. Finally, Royal Bank Of Canada increased their price objective on HCA Holdings from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Friday, October 28th. Eight equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $88.16.

In other news, insider Michael S. Cuffe sold 4,300 shares of the stock in a transaction on Monday, January 9th. The stock was sold at an average price of $78.00, for a total value of $335,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP P. Martin Paslick sold 36,004 shares of the stock in a transaction on Friday, October 28th. The shares were sold at an average price of $78.79, for a total value of $2,836,755.16. Following the completion of the transaction, the senior vice president now owns 35,894 shares of the company’s stock, valued at $2,828,088.26. The disclosure for this sale can be found here. 3.10% of the stock is owned by insiders.

HCA Holdings Company Profile

HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.

5 Day Chart for NYSE:HCA

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.